Get started
Henry Schein, Inc.Henry Schein, Inc.Henry Schein, Inc.

Henry Schein, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

HSIC chart


Full chart

HSIC upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.71 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
28.24
Basic EPS (TTM)
2.46 USD
Net income (FY)
‪416.00 M‬ USD
Revenue (FY)
‪12.34 B‬ USD
Shares float
‪123.00 M‬
Beta (1Y)
0.44

Employees


Employees (FY)
‪25 K‬
Change (1Y)
‪+3 K‬ +13.64%
Revenue / Employee (1Y)
‪493.56 K‬ USD
Net income / Employee (1Y)
‪16.64 K‬ USD

About Henry Schein, Inc.


Sector
Distribution Services
Industry
Medical Distributors
CEO
Stanley M. Bergman
Website
henryschein.com
Headquarters
Melville
Founded
1932
FIGI
BBG000BNMMJ3
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HSIC news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HSIC is 69.82 USD — it has increased by 1.26% in the past 24 hours. Watch Henry Schein, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Henry Schein, Inc. stocks are traded under the ticker HSIC.
HSIC stock has fallen by −9.58% compared to the previous week, the month change is a −6.82% fall, over the last year Henry Schein, Inc. has showed a −5.37% decrease.
We've gathered analysts' opinions on Henry Schein, Inc. future price: according to them, HSIC price has a max estimate of 83.00 USD and a min estimate of 55.00 USD. Watch HSIC chart and read a more detailed Henry Schein, Inc. stock forecast: see what analysts think of Henry Schein, Inc. and suggest that you do with its stocks.
HSIC reached its all-time high on Apr 14, 2022 with the price of 92.68 USD, and its all-time low was 2.03 USD and was reached on Oct 22, 1999. View more price dynamics on HSIC chart.
See other stocks reaching their highest and lowest prices.
HSIC stock is 2.78% volatile and has beta coefficient of 0.44. Track Henry Schein, Inc. stock price on the chart and check out the list of the most volatile stocks — is Henry Schein, Inc. there?
Today Henry Schein, Inc. has the market capitalization of ‪8.71 B‬, it has decreased by −4.78% over the last week.
Yes, you can track Henry Schein, Inc. financials in yearly and quarterly reports right on TradingView.
Henry Schein, Inc. is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
HSIC earnings for the last quarter are 1.22 USD per share, whereas the estimation was 1.17 USD resulting in a 4.29% surprise. The estimated earnings for the next quarter are 1.23 USD per share. See more details about Henry Schein, Inc. earnings.
Henry Schein, Inc. revenue for the last quarter amounts to ‪3.17 B‬ USD, despite the estimated figure of ‪3.24 B‬ USD. In the next quarter, revenue is expected to reach ‪3.35 B‬ USD.
HSIC net income for the last quarter is ‪99.00 M‬ USD, while the quarter before that showed ‪104.00 M‬ USD of net income which accounts for −4.81% change. Track more Henry Schein, Inc. financial stats to get the full picture.
No, HSIC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has ‪25.00 K‬ employees. See our rating of the largest employees — is Henry Schein, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Henry Schein, Inc. EBITDA is ‪888.00 M‬ USD, and current EBITDA margin is 7.80%. See more stats in Henry Schein, Inc. financial statements.
Like other stocks, HSIC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Henry Schein, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Henry Schein, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Henry Schein, Inc. stock shows the sell signal. See more of Henry Schein, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.